MedPath

Mechanical and Electrical Dyssynchrony During His-Bundle Pacing Versus His-Bundle Area Right Ventricular Pacing

Recruiting
Conditions
Bradyarrhythmia
Registration Number
NCT04697797
Lead Sponsor
Medical University of Lodz
Brief Summary

The aim of this study is to evaluate mechanical and electrical cardiac dyssynchrony in patients with pacemakers and the right ventricular electrode implanted in His Bundle area.

Detailed Description

Permanent His Bundle Pacing (HBP) is a well-known method of cardiac pacing which is increasingly used in everyday practice. After lead implantation in His Bundle area (HBA) capture of various tissues can be achieved: A. right ventricular myocardium near to HBP; B. cardiac conduction system selectively or nonselectively (with concomitant regional myocardium activation). The different excitability and refractory periods decide which tissue, myocardium or/and the conduction system is effectively paced. A lot of clinical trials revealed the advantage of HBP over apical ventricular pacing (AVP). HBP improves clinical (NYHA, quality of life, hospitalization rate) and echocardiographic (left ventricular dimension and ejection fraction) indicators of heart failure.

We are going to compare mechanical and electrical synchrony during the various type of myocardium activation: HBP (nsHBP or sHBP), RV pacing near HBA and native heart rhythm (if possible) in each patient recruited to the study. Adequate pacemaker programming will allow achieving different activations as shown above. The mechanical synchrony will be estimated by transthoracic echocardiography and the electrical one by the detailed analysis of ECG.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
100
Inclusion Criteria
  • all adult patients after implantation of pacemaker system with pacing lead successfully captured His Bundle (selectively or/and nonselectively)
Exclusion Criteria
  • not willing or incapable to give written informed consent;
  • previous implanted cardiac electronic device (pacemaker, implantable cardioverter-defibrillator, cardiac resynchronization therapy device)

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Interventricular mechanical delayLong term: 12-15 months after pacemaker implantation

InterVentricular Mechanical Dyssynchrony Parameter 1

Free-wall-LV-to-RV-delayLong term: 12-15 months after pacemaker implantation

InterVentricular Mechanical Dyssynchrony Parameter 2

systolic dyssynchrony indexMid-term: 3-6 months after pacemaker implantation

Ventricular Mechanical Dyssynchrony Parameter 1

Septal-to-posterior wall motion delayLong term: 12-15 months after pacemaker implantation

IntraVentricular Mechanical Dyssynchrony Parameter 1

Opposing wall motion delayMid-term: 3-6 months after pacemaker implantation

IntraVentricular Mechanical Dyssynchrony Parameter 2

QRS durationLong term: 12-15 months after pacemaker implantation

Electrical dyssynchrony Parameter

Secondary Outcome Measures
NameTimeMethod
Radial strainLong term: 12-15 months after pacemaker implantation

Additional Ventricular Mechanical Dyssynchrony Parameter 1

Global longitudinal strainLong term: 12-15 months after pacemaker implantation

Global left ventricle function parameter 2

Left Ventricular Ejection FractionLong term: 12-15 months after pacemaker implantation

Global left ventricle function parameter

Left ventricular output track velocity-time integralLong term: 12-15 months after pacemaker implantation

Global left ventricle function parameter 3

Diastolic Filling TimeLong term: 12-15 months after pacemaker implantation

Atrioventricular Dyssynchrony Parameter

Trial Locations

Locations (1)

Department of Electrocardiology Medical University of Lodz

🇵🇱

Lodz, Poland

© Copyright 2025. All Rights Reserved by MedPath